SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-075395
Filing Date
2018-03-08
Accepted
2018-03-08 17:23:56
Documents
6
Period of Report
2018-03-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d539411d8k.htm 8-K 20878
2 EX-1.1 d539411dex11.htm EX-1.1 177119
3 EX-5.1 d539411dex51.htm EX-5.1 7404
4 EX-99.1 d539411dex991.htm EX-99.1 9770
5 GRAPHIC g539411dsp41.gif GRAPHIC 1045
6 GRAPHIC g539411g0308095335544.jpg GRAPHIC 3603
  Complete submission text file 0001193125-18-075395.txt   223061
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: GA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37783 | Film No.: 18677497
SIC: 2834 Pharmaceutical Preparations